News

Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity
Novo Nordisk A/S (NYSE: NVO) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company highlights ...
Firstpost16d
Will Indians get blockbuster weight-loss drugs at cost of cheaper insulin?
Novo Nordisk has said that the pens it uses for human insulin are not the same as those for its GLP-1 agonists Wegovy - a weight-loss treatment - and Ozempic, a diabetes drug. Boxes of Wegovy move ...